GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (NAS:NEOG) » Definitions » Cyclically Adjusted PB Ratio

Neogen (Neogen) Cyclically Adjusted PB Ratio : 1.54 (As of Apr. 28, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Neogen Cyclically Adjusted PB Ratio?

As of today (2024-04-28), Neogen's current share price is $12.14. Neogen's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 was $7.87. Neogen's Cyclically Adjusted PB Ratio for today is 1.54.

The historical rank and industry rank for Neogen's Cyclically Adjusted PB Ratio or its related term are showing as below:

NEOG' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.48   Med: 8.96   Max: 14.89
Current: 1.54

During the past years, Neogen's highest Cyclically Adjusted PB Ratio was 14.89. The lowest was 1.48. And the median was 8.96.

NEOG's Cyclically Adjusted PB Ratio is ranked better than
61.07% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.98 vs NEOG: 1.54

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Neogen's adjusted book value per share data for the three months ended in Feb. 2024 was $14.525. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $7.87 for the trailing ten years ended in Feb. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Neogen Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Neogen's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Cyclically Adjusted PB Ratio Chart

Neogen Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.79 8.70 9.56 4.56 2.50

Neogen Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.66 2.50 3.15 2.23 2.18

Competitive Comparison of Neogen's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Neogen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neogen's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Neogen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Neogen's Cyclically Adjusted PB Ratio falls into.



Neogen Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Neogen's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=12.14/7.87
=1.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 is calculated as:

For example, Neogen's adjusted Book Value per Share data for the three months ended in Feb. 2024 was:

Adj_Book=Book Value per Share/CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=14.525/129.4194*129.4194
=14.525

Current CPI (Feb. 2024) = 129.4194.

Neogen Quarterly Data

Book Value per Share CPI Adj_Book
201405 3.128 100.373 4.033
201408 3.239 100.352 4.177
201411 3.316 99.635 4.307
201502 3.409 99.032 4.455
201505 3.545 100.333 4.573
201508 3.672 100.548 4.726
201511 3.784 100.135 4.891
201602 3.876 100.040 5.014
201605 4.035 101.355 5.152
201608 4.149 101.617 5.284
201611 4.293 101.829 5.456
201702 4.442 102.779 5.593
201705 4.630 103.256 5.803
201708 4.777 103.587 5.968
201711 5.051 104.072 6.281
201802 5.250 105.052 6.468
201805 5.414 106.148 6.601
201808 5.593 106.383 6.804
201811 5.780 106.338 7.035
201902 5.947 106.649 7.217
201905 6.108 108.048 7.316
201908 6.298 108.245 7.530
201911 6.554 108.519 7.816
202002 6.727 109.139 7.977
202005 6.848 108.175 8.193
202008 7.085 109.662 8.361
202011 7.300 109.793 8.605
202102 7.547 110.968 8.802
202105 7.820 113.576 8.911
202108 7.957 115.421 8.922
202111 8.031 117.269 8.863
202202 8.121 119.703 8.780
202205 8.232 123.323 8.639
202208 8.196 124.958 8.489
202211 14.371 125.607 14.807
202302 14.455 126.928 14.739
202305 14.494 128.314 14.619
202308 14.545 129.538 14.532
202311 14.537 129.548 14.523
202402 14.525 129.419 14.525

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Neogen  (NAS:NEOG) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Neogen Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Neogen's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Neogen (Neogen) Business Description

Traded in Other Exchanges
Address
620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Executives
William T Boehm director
Douglas Edward Jones officer: Vice President, CCO 620 LESHER PLACE, LANSING MI 48912
Jason Warren Lilly officer: Vice President 620 LESHER PLACE, LANSING MI 48912
James P Tobin director 620 LESHER PLACE, LANSING MI 48895
David H. Naemura officer: VP & CFO C/O GATES INDUSTRIAL CORPORATION PLC, 1144 FIFTEENTH STREET, SUITE 1400, DENVER CO 80202
Amy M Rocklin officer: Chief Legal & Reg. Officer 620 LESHER PLACE, LANSING MI 48912
Steven J. Quinlan officer: VP & CFO 620 LESHER PLACE, LANSING MI 48912
Jeffrey D Capello director C/O NEOGEN CORP., 620 LESHER PLACE, LANSING MI 48912
Aashima Gupta director C/O NEOGEN CORPORATION, 620 LESHER PLACE, LANSING MI 48912
John Edward Adent officer: Chief Executive Officer 822 7TH STREET, SUITE 740, GREELEY CO 80631
Darci L Vetter director 620 LESHER PLACE, LANSING MI 48912
Ronald D Green director 620 LESHER PLACE, LANSING MI 48912
James C Borel director 1007 MARKET STREET, WILMINGTON DE 19898
Terri A Morrical officer: General Manager
G Bruce Papesh director 726 APPLEGATE LANE, EAST LANSING MI 48823